158 related articles for article (PubMed ID: 6285153)
1. Endocrinological features and endometrial morphology in climacteric women receiving hormone replacement therapy.
Grasso A; Baraghini F; Barbieri C; Dalla Vecchia E; Previdi AM; Di Renzo GC; Volpe A
Maturitas; 1982 Apr; 4(1):19-26. PubMed ID: 6285153
[TBL] [Abstract][Full Text] [Related]
2. An intrauterine progesterone contraceptive system (52 mg) used in pre- and peri-menopausal patients with endometrial hyperplasia.
Volpe A; Botticelli A; Abrate M; Dalla Vecchia E; Mantovani M; Carani C; Grasso A; Mazza V; Di Renzo GC
Maturitas; 1982 Apr; 4(1):73-9. PubMed ID: 6285154
[TBL] [Abstract][Full Text] [Related]
3. Plasma oestrone, oestradiol and gonadotrophin concentrations in postmenopausal patients treated with oestradiol or with a combination of oestradiol and oestriol.
Sipinen S
Ann Clin Res; 1979 Oct; 11(5):172-8. PubMed ID: 121048
[TBL] [Abstract][Full Text] [Related]
4. The effect of 2 mg estradiol-17 beta plus 1 mg estriol, sequentially combined with 1 mg norethisteroneacetate, on LH, FSH, estradiol-17 beta, progesterone, testosterone and prolactin after ovariectomy.
Kemeter P; Bernaschek G; Altmann G; Feichtinger W
Arch Gynecol; 1984; 234(3):219-29. PubMed ID: 6428330
[TBL] [Abstract][Full Text] [Related]
5. Oestrogens, gonadotropins and prolactin after intra-vaginal administration of oestriol in post-menopausal women.
Keller PJ; Riedmann R; Fischer M; Gerber C
Maturitas; 1981 Mar; 3(1):47-53. PubMed ID: 6789033
[TBL] [Abstract][Full Text] [Related]
6. Time-related effects of a progestogen on the isoforms of serum gonadotrophins in 17 beta-oestradiol treated post-menopausal women.
Wide L; Naessén T; Eriksson K; Rune C
Clin Endocrinol (Oxf); 1996 Jun; 44(6):651-8. PubMed ID: 8759177
[TBL] [Abstract][Full Text] [Related]
7. Treatment of climacteric and postmenopausal women with 17-beta-oestradiol and norethisterone acetate.
Furuhjelm M; Carlström K
Acta Obstet Gynecol Scand; 1977; 56(4):351-61. PubMed ID: 602703
[TBL] [Abstract][Full Text] [Related]
8. Antagonism of oestrogen-induced prolactin release by medroxyprogesterone acetate.
Castelo-Branco C; Palacios S; Martinez de Osaba MJ; Balasch J; Fortuny A; Vanrell J
Maturitas; 1994 Dec; 20(2-3):145-50. PubMed ID: 7715466
[TBL] [Abstract][Full Text] [Related]
9. Relation between plasma hormone profiles, symptoms, and response to oestrogen treatment in women approaching the menopause.
Chakravarti S; Collins WP; Thom MH; Studd JW
Br Med J; 1979 Apr; 1(6169):983-5. PubMed ID: 219937
[TBL] [Abstract][Full Text] [Related]
10. Comparison of a triphasic oestradiol/norethisterone acetate preparation with and without an oestriol component in the treatment of climacteric complaints.
Hellberg D; Nilsson S
Maturitas; 1984 Apr; 5(4):233-43. PubMed ID: 6429481
[TBL] [Abstract][Full Text] [Related]
11. [Serum hormone level and Kupperman menopausal complaints in sexually mature women with disturbance of ovulation].
Kano T; Nishikawa K
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jan; 37(1):31-7. PubMed ID: 3919122
[TBL] [Abstract][Full Text] [Related]
12. The significance of oestriol in the management of the post-menopause.
Tzingounis VA; Aksu MF; Greenblatt RB
Acta Endocrinol Suppl (Copenh); 1980; 233():45-50. PubMed ID: 6773286
[TBL] [Abstract][Full Text] [Related]
13. Influence of conjugated oestrogens on circulating oestradiol, oestrone, LH, FSH and prolactin levels in postmenopausal women.
Luisi M; Franchi F; Argenio GF; Barletta D; Romano MR; Bernini GP; Gasperi M; Sgrilli R
Int J Tissue React; 1981 Jun; 3(2):77-81. PubMed ID: 6799393
[TBL] [Abstract][Full Text] [Related]
14. Serum prolactin, gonadotrophin and oestrogen levels in women receiving hormone replacement therapy.
Lind T; Cameron EH; Hunter WM
Br J Obstet Gynaecol; 1978 Feb; 85(2):138-41. PubMed ID: 626723
[TBL] [Abstract][Full Text] [Related]
15. Endocrine studies in postmenopausal women during oral replacement therapy with unconjugated oestrogens.
Vasquez JM; Samaras CA; Nezhat C
Reproduccion; 1982; 6(2):49-59. PubMed ID: 6216132
[TBL] [Abstract][Full Text] [Related]
16. Hormone serum levels and hormone receptor contents of endometria in women with normal menstrual cycles and patients bearing endometrial carcinoma.
Spona J; Ulm R; Bieglmayer C; Husslein P
Gynecol Obstet Invest; 1979; 10(2-3):71-80. PubMed ID: 535775
[TBL] [Abstract][Full Text] [Related]
17. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
[TBL] [Abstract][Full Text] [Related]
18. Benefits and risks of different hormonal replacement therapies in post-menopausal women.
Volpe A; Facchinetti F; Grasso A; Petraglia F; Campanini D; Genazzani AR
Maturitas; 1986 Dec; 8(4):327-34. PubMed ID: 3033444
[TBL] [Abstract][Full Text] [Related]
19. Effects of a continuous estrogen-progestogen therapy for climacteric symptoms on circulating sex steroids and gonadotrophins.
Mattsson LA; Abrahamsson L; Cullberg G; Samsioe G
Arch Gynecol; 1983; 233(2):101-7. PubMed ID: 6683955
[TBL] [Abstract][Full Text] [Related]
20. Serum concentrations of oestrone, oestradiol and oestriol during various oestrogen treatments.
Rauramo L; Punnonen R; Grönroos M
Maturitas; 1981 Aug; 3(2):183-6. PubMed ID: 7289888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
